KING OF PRUSSIA, Pa., March 1, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York, New York on Thursday, March 2, 2023 at 3:30pm (EST).
A live audio webcast of the presentation will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, a replay of the presentation will be available on the Company's website for 90 days following the conference.
Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.
| Last Trade: | US$218.69 |
| Daily Change: | -6.61 -2.93 |
| Daily Volume: | 637,993 |
| Market Cap: | US$12.330B |
October 29, 2025 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
